Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Literature
1.
Karagiannidis C, Strassmann S, Schwarz S, Merten M, Fan E, Beck J, Sinderby C, Windisch W. Control of respiratory drive by extracorporeal CO2 removal in acute exacerbation of COPD breathing on non-invasive NAVA. Crit Care. 2019;23(1):135.CrossRef
2.
Abrams D, Roncon-Albuquerque R Jr, Brodie D. What’s new in extracorporeal carbon dioxide removal for COPD? Intensive Care Med. 2015;41(5):906–8.CrossRef
3.
Diehl JL, Mercat A, Pesenti A. Understanding hypoxemia on ECCO2R: back to the alveolar gas equation. Intensive Care Med. 2019;45(2):255–6.CrossRef
4.
Del Sorbo L, Fan E, Nava S, Ranieri VM. ECCO2R in COPD exacerbation only for the right patients and with the right strategy. Intensive Care Med. 2016;42(11):1830–1.CrossRef
5.
Li M, Gu SC, Xia JG, Zhan QY. Acute exacerbation of chronic obstructive pulmonary disease treated by extracorporeal carbon dioxide removal. Chin Med J. 2019;132(20):2505–7.CrossRef
Metadata
Title
ECCO2R and NIV-NAVA for stepwise early weaning in extremely severe COPD patients: a promising solution with details to be defined
Authors
Heyan Wang
Hangyong He
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-2735-8

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue

Research

Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness

Letter

Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated!

Research

Automated vs. conventional ventilation in the ICU: a randomized controlled crossover trial comparing blood oxygen saturation during daily nursing procedures (I-NURSING)

Research Letter

Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial

Research Letter

The value of plasma pro-enkephalin and adrenomedullin for the prediction of sepsis-associated acute kidney injury in critically ill patients

Correction

Correction to: Real-time shear wave ultrasound elastography: a new tool for the evaluation of diaphragm and limb muscle stiffness in critically ill patients